Javascript must be enabled to continue!
208. TRIHEXYPHENIDYL REDUCES FLASHBACKS IN PATIENTS WITH POSTTRAUMATIC STRESS DISORDER (PTSD)
View through CrossRef
Abstract
Background
Post-Traumatic Stress Disorder (PTSD) is a complex mental health condition triggered by experiencing or witnessing traumatic events. Despite extensive research, the precise mechanisms underlying PTSD remain unclear. Recent data from patients have shown that central cholinergic agents targeting the basal forebrain nucleus AcH4 and the amygdala, which are involved in memory-related circuits, have demonstrated dramatic effects in alleviating PTSD symptoms.
Aims & Objectives
This study aims to develop a new therapy for reducing flashbacks in the posttraumatic stress disorder (PTSD).
Method
Previous studies have proved the potentiality of anticholinergic in reducing flashbacks in PTSD. This report describes the effects of the central anticholinergic drug trihexyphenidyl, which penetrates the blood–brain barrier (BBB) among 7 patients suffering from PTSD flashbacks.
Results
Drug effects were assessed using psychological tests, including a self-evaluation score, the IES-R (Impact of Events Scale-Revised), and CAPS (Clinician-administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders-IV [DSMIV]).The mean of the self-evaluation score improved from 100 to 17.14 after the treatment, and the mean IES-R score improved to 25.57 from 70.42. The CAPS mean frequency (F) and intensity (I) of B-1(unwanted memories) improved from 3.42 to0.71and 3.42 to 0.57, respectively, after treatment. The mean F and I of B-2 (unpleasant dreams) improved from 1.85 to 0.42and 2.00 to 0.28, respectively. The mean of F and I of B-3 (flashbacks, etc.) improved from 3.71 to 0.85 and 3.28 to 0.85, respectively. Complete remission was achieved in 3 of 7 cases (48%), and partial remission was achieved for the remaining 4 (52%). Therefore, at least some remission was achieved in all patients in this study.
Discussion & Conclusions
The central anticholinergic drug trihexyphenidyl is a novel and successful medical therapy in reducing flashbacks in subjects suffering from PTSD. This result suggests that the origin of flashbacks in PTSD is closely related to abnormal excitement of memory-related circuits comprised of the acetylcholine-based basal forebrain, amygdala, and hippocampus.
Title: 208. TRIHEXYPHENIDYL REDUCES FLASHBACKS IN PATIENTS WITH POSTTRAUMATIC STRESS DISORDER (PTSD)
Description:
Abstract
Background
Post-Traumatic Stress Disorder (PTSD) is a complex mental health condition triggered by experiencing or witnessing traumatic events.
Despite extensive research, the precise mechanisms underlying PTSD remain unclear.
Recent data from patients have shown that central cholinergic agents targeting the basal forebrain nucleus AcH4 and the amygdala, which are involved in memory-related circuits, have demonstrated dramatic effects in alleviating PTSD symptoms.
Aims & Objectives
This study aims to develop a new therapy for reducing flashbacks in the posttraumatic stress disorder (PTSD).
Method
Previous studies have proved the potentiality of anticholinergic in reducing flashbacks in PTSD.
This report describes the effects of the central anticholinergic drug trihexyphenidyl, which penetrates the blood–brain barrier (BBB) among 7 patients suffering from PTSD flashbacks.
Results
Drug effects were assessed using psychological tests, including a self-evaluation score, the IES-R (Impact of Events Scale-Revised), and CAPS (Clinician-administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders-IV [DSMIV]).
The mean of the self-evaluation score improved from 100 to 17.
14 after the treatment, and the mean IES-R score improved to 25.
57 from 70.
42.
The CAPS mean frequency (F) and intensity (I) of B-1(unwanted memories) improved from 3.
42 to0.
71and 3.
42 to 0.
57, respectively, after treatment.
The mean F and I of B-2 (unpleasant dreams) improved from 1.
85 to 0.
42and 2.
00 to 0.
28, respectively.
The mean of F and I of B-3 (flashbacks, etc.
) improved from 3.
71 to 0.
85 and 3.
28 to 0.
85, respectively.
Complete remission was achieved in 3 of 7 cases (48%), and partial remission was achieved for the remaining 4 (52%).
Therefore, at least some remission was achieved in all patients in this study.
Discussion & Conclusions
The central anticholinergic drug trihexyphenidyl is a novel and successful medical therapy in reducing flashbacks in subjects suffering from PTSD.
This result suggests that the origin of flashbacks in PTSD is closely related to abnormal excitement of memory-related circuits comprised of the acetylcholine-based basal forebrain, amygdala, and hippocampus.
Related Results
Psychomotor diagnostics and treatment for posttraumatic stress disorder
Psychomotor diagnostics and treatment for posttraumatic stress disorder
Despite the proven effectiveness of treatments like cognitive behavioural therapy and EMDR, many PTSD patients continue to experience symptoms. A recent meta-analysis showed that t...
Increased risk of attempted suicide in Australian veterans is associated with total and permanent incapacitation, unemployment and posttraumatic stress disorder severity
Increased risk of attempted suicide in Australian veterans is associated with total and permanent incapacitation, unemployment and posttraumatic stress disorder severity
Background: Military veterans have higher rates of suicidality and completed suicides compared to the general population. Previous research has demonstrated suicidal behaviour is h...
Investigation of Posttraumatic Stress Disorder in Children After Animal-Induced Injury in China
Investigation of Posttraumatic Stress Disorder in Children After Animal-Induced Injury in China
OBJECTIVE:Dogs are important members of many families in many countries. However, posttraumatic stress disorder (PTSD) in children after animal attacks has always been underestimat...
Stress levels in veterans with PTSD and equines during therapeutic horseback riding
Stress levels in veterans with PTSD and equines during therapeutic horseback riding
Military Veterans are at risk of developing posttraumatic stress disorder (PTSD) following exposure to combat while on deployment. Up to 30 percent of Veterans suffer from PTSD and...
Exploring the nexus between post-traumatic stress disorder and patriarchy: a gender-based variation
Exploring the nexus between post-traumatic stress disorder and patriarchy: a gender-based variation
Respected Editor,
Post-traumatic stress disorder (PTSD) is a psychological disorder resulting from witnessing or experiencing trauma, aggravated by repeated exposure to stress and ...
Natural Course of Co‐Occurring PTSD and Alcohol Use Disorder Among Recent Combat Veterans
Natural Course of Co‐Occurring PTSD and Alcohol Use Disorder Among Recent Combat Veterans
Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) commonly co‐occur in veterans, yet little is known about the longitudinal course of PTSD and drinking in comorbi...
Somatic correlates of post-traumatic stress disorder
Somatic correlates of post-traumatic stress disorder
The article presents the results of a content analysis of modern foreign studies aimed at identifying somatic correlates of post-traumatic stress disorder. It is noted that today i...
Idiographic Temporal Dynamics of Posttraumatic Stress Disorder (PTSD) Symptom Dimensions in Daily Life
Idiographic Temporal Dynamics of Posttraumatic Stress Disorder (PTSD) Symptom Dimensions in Daily Life
Understanding temporal relations among posttraumatic stress disorder (PTSD) symptom dimensions has received increasing attention in research. However, current findings in this area...

